TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

A$120 Million (aud)

Avita Medical Limited

PIPE

Financial Advisor, November 2019

Avita Medical Limited
Institutional Placement

Avita Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. Avita Medical’s patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing a REGENERATIVE EPIDERMAL SUSPENSION™ (“RES™”), an autologous suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.